and the description of intragenic polymorphic restriction sites.2 RFLP analysis has been found to be informative for prenatal diagnosis in 70% to over 90% of at risk families in various European populations.3-6However, compared to methods based on PCR amplified DNA, prenatal detection of Mendelian disorders by genomic Southern blot analysis has some well known limitations. Direct detection of mutation is a convenient diagnostic tool, but its feasibility is largely dependent on the extent of genetic heterogeneity of the disease in the target population. Sufficient information is now available to show the heterogeneous molecular basis of PKU, both in terms of numerous allelic mutations and interpopulation differences. Therefore, the molecular diagnosis of the disease is not an easy task and the increasing number of newly detected mutations adds to this complexity.
During a study of molecular defects leading to PKU in various Caucasian populations, we have identified three silent mutations in the PAH gene which are linked to specific polymorphic haplotypes in all ethnic groups investigated. Part of these findings has been published elsewhere. 7 Here we discuss the possible use of these mutations as diagnostic markers for the prenatal detection of PKU.
Materials and methods A total of 160 normal and mutant PAH alleles of German, Bulgarian, Italian, Turkish, and Lithuanian ethnic background were included in the study. RFLP analysis and haplotype assignment were as described previously.2 The cDNA probe phPAH247 was kindly provided by Dr S L C Woo.
Direct sequencing of exons 6, 7, and 11 of the PAH gene was performed on single stranded DNA templates obtained by asymmetrical amplification.8 Amplification and sequencing primers for exon 7 have been reported previously7 and those for exons 6 and 11 are shown in figs 1 and 2.
Direct restriction analysis was performed after amplification of exons 6, 7, and 11 of the PAH gene. The restriction sites used were DdeI for the detection of the silent mutation in exon 6, AluI for the mutation in exon 7, and MnlI for exon 11. The Figure 3 Pedigree showing the diagnostic use of the silent mutations in the PAH gene.
The different informativeness is the result of the differences in haplotype distribution in the two populations. In PKU families originating from the western part of Germany, haplotype 3 has been reported to account for 11 % of mutant PAH alleles,4 whereas in eastern and southern European populations it is virtually absent.56 In addition, haplotype 4 has a higher frequency on both normal and mutant alleles in Germany than in Bulgaria.46 DESIGNING A MINIMUM DIAGNOSTIC PANEL Regardless of molecular heterogeneity, one, or the major, PKU mutation has been reported to account for a large proportion of mutant alleles in most Caucasian populations studied. We have therefore estimated the informativeness of a minimum panel of diagnostic tests, including the silent mutations in the PAH gene and two PKU mutations, in the ethnic groups investigated. The amino acid substitution in codon 4088 and a newly detected frequent splicing defect in the PAH gene9 were selected on the basis of previously reported findings concerning the predominant PKU mutations in these populations.46101 The data on the combined use of the silent mutations together with the most common PKU defects are presented in table 3. This approach makes prenatal diagnosis of PKU fully informative in 73% of Lithuanian, 62% of Bulgarian, and 46% of West German PKU families. The proportion of uninformative families in Bulgaria and Lithuania is reduced to 7 to 8%. Informativeness is lower in populations where haplotype 1 is 
